P53 associated with cathepsin D in primary breast cancer (original) (raw)
Relation between cathepsin D expression and other prognostic factors in breast carcinomas
James Wittliff
Clinical chemistry, 1995
View PDFchevron_right
Immunoradiometric assay of cathepsin D: Estrogen regulated vs. non estrogen- regulated cathepsin D expression in relation to clinicopathological features of breast cancer
Ksenija Kanjer
Archive of oncology, 2002
View PDFchevron_right
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study
James Henry
Cancer, 1990
View PDFchevron_right
Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings
Niall OHiggins
Clinical chemistry, 1991
View PDFchevron_right
Relationship between Cathepsin-D and Other Prognostic Factors in Human Breast Cancer
Julián Mosto
Tumori Journal, 1997
View PDFchevron_right
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer
Renzo Barbazza
European Journal of Cancer, 1995
View PDFchevron_right
A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol
Pascal Pujol
Cancer, 1993
View PDFchevron_right
Relation of cathepsin D level to the estrogen receptor in human breast cancer
Santo Marsigliante
International journal of clinical & laboratory research, 1992
View PDFchevron_right
Correlation of two methods for determination of cathepsin D in breast carcinoma (immunohistochemistry and ELISA in cytosol)
Stjepan Gamulin
Breast Cancer Research and Treatment, 1997
View PDFchevron_right
Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis
Tamara Lah
Human Pathology, 2000
View PDFchevron_right
Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues
Gilles Freiss, Marcel Garcia
Clinical chemistry, 1989
View PDFchevron_right
Expression profile of cathepsins indicates the potential of cathepsins B and D as prognostic factors in breast cancer patients
Daqing Jiang
Oncology Letters, 2015
View PDFchevron_right
Biological and Clinical Significance of Cathepsin D in Breast Cancer
Henri Rochefort
Acta Oncologica, 1992
View PDFchevron_right
Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer
Michaela Denk
European Journal of Cancer, 1998
View PDFchevron_right
Significance of Cathepsin-D expression in uterine tumours
M. Distefano
European Journal of Cancer, 1995
View PDFchevron_right
Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: …
Marcel Garcia
Cancer research
View PDFchevron_right
Cathepsin D versus Other Prognostic Factors in Breast Cancer. Results and Controversies of a Multicenter Study on 2575 Cases
Ruggero Dittadi
The International Journal of Biological Markers, 1996
View PDFchevron_right
Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls
Santo Longo
Cancer research, 1994
View PDFchevron_right
Characterization and Properties of Two Monoclonal Antibodies Specific for the MT 52,000 Precursor of Cathepsin D in Human Breast Cancer Cells1
Gilles Freiss
Cancer Research
View PDFchevron_right
Reevaluating Cathepsin D as a biomarker for breast cancer: Serum activity levels versus histopathology
Seema Khan
Cancer Biology & Therapy, 2010
View PDFchevron_right
The estrogen-regulated 52K-cathepsin-D in breast cancer: From biology to clinical applications
Patrick Augereau
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
View PDFchevron_right
Association between High Concentrations of Mr 52,000 Cathepsin D and Poor Prognosis in Primary Human Breast Cancer
Henri Rochefort
Cancer Research, 1989
View PDFchevron_right
Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells
Henri Rochefort
Biochimie, 1988
View PDFchevron_right
Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells
Philippe Montcourrier
Cancer research, 1989
View PDFchevron_right
Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters
Gilles Freiss, Marcel Garcia
Cancer research, 1988
View PDFchevron_right
Immunohistochemical visualisation of cathepsin-D expression in breast cancer
Ioannis Mylonas
Anticancer research
View PDFchevron_right
Western Immunoblotting and Enzymatic Activity Analysis of Cathepsin D In Human Breast Cancer Cell Lines of Different Invasive Potential. Regulation by 17β-Estradiol, …
Claude Remacle
Clinical and …, 1997
View PDFchevron_right
Western blotting and isoform analysis of cathepsin D from normal and malignant human breast cell lines
Santo Longo
Breast Cancer Research and Treatment, 1995
View PDFchevron_right
Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification
Francisco Vera Sempere
Clinica Chimica Acta, 1996
View PDFchevron_right